The hydrocephalus market size has grown strongly in recent years. It will grow from $3.66 billion in 2025 to $3.87 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to improvements in neuroimaging availability, increased awareness of neurological conditions, expansion of hospital neurology departments, growth in pediatric neurosurgery practices, availability of diagnostic imaging infrastructure.
The hydrocephalus market size is expected to see strong growth in the next few years. It will grow to $4.79 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing investments in neurological research, rising demand for early diagnosis solutions, expansion of advanced imaging technologies, growing focus on minimally invasive treatments, increased funding for neurological healthcare. Major trends in the forecast period include increasing use of advanced neuroimaging techniques, rising adoption of early diagnostic screening, growing focus on pediatric hydrocephalus management, expansion of clinical research in neurological disorders, enhanced integration of data-driven diagnostics.
The swift growth of healthcare infrastructure is anticipated to drive the hydrocephalus market in the coming years. Healthcare infrastructure encompasses the system of buildings, organizations, and resources dedicated to promoting, restoring, and maintaining health. It consists of various components that collaborate to provide healthcare services to individuals and communities. A well-developed healthcare infrastructure is essential for delivering comprehensive and specialized treatment to patients with hydrocephalus. It facilitates prompt diagnosis, appropriate therapy, and ongoing care, all of which contribute to better outcomes for individuals affected by this condition. For example, in May 2023, the American Health Care Association, a US-based nonprofit organization, reported that the United States had 6,129 hospitals, reflecting a 0.591% increase from 6,093 hospitals in the previous year. Therefore, the rapid expansion of healthcare infrastructure is propelling the hydrocephalus market.
Leading companies in the hydrocephalus market are innovating advanced products, including endovascularly implantable cerebrospinal fluid (CSF) shunts, to enhance the management of hydrocephalus by offering minimally invasive solutions for regulating CSF flow and alleviating intracranial pressure. An endovascularly implantable CSF shunt is a type of shunt system positioned within blood vessels (endovascularly) to address hydrocephalus, a condition marked by excessive CSF accumulation in the brain. For example, in August 2024, CereVasc Inc., a clinical-stage medical device company based in the US, received approval from the Food and Drug Administration (FDA) for its eShunt System. This medical device is designed for treating Normal Pressure Hydrocephalus (NPH) and includes an endovascularly implantable CSF shunt that aims to eliminate the need for invasive surgery and general anesthesia. The implantation of the eShunt will be conducted under local anesthesia using a minimally invasive femoral venous approach in an angiography suite, which is a specialized medical facility.
In June 2023, CereVasc, Inc., a US-based clinical-stage medical device company focused on treatments for communicating hydrocephalus, announced a corporate partnership with LianMedical to expand hydrocephalus care in Asia. Through this collaboration, the companies aim to address unmet needs in hydrocephalus treatment by making minimally invasive solutions for communicating hydrocephalus available to a broader patient population. LianMedical is a China-based medical device company.
Major companies operating in the hydrocephalus market are Johnson & Johnson Corporation, Medtronic plc, MIZUHO Co. Ltd., B. Braun Melsungen AG, Helios Hospital, Texas Children's Hospital, Boston Children’s Hospital, Karl Storz SE and Co. KG, Integra LifeSciences Corporation, Children's National Hospital, Natus Medical Incorporated, Aesculap Inc., Sophysa SA, Anadolu Medical Center, Christoph Miethke GmbH & Co. KG, Moller Medical GmbH, Spiegelberg GmbH & Co. KG, Delta Surgical Limited, Kaneka Medix Corporation, Tokibo Co. Ltd.
North America was the largest region in the hydrocephalus market in 2025. The regions covered in the hydrocephalus market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hydrocephalus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the hydrocephalus market by increasing costs of imported imaging equipment, diagnostic devices, surgical tools, and electronic monitoring systems. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported medical technologies, while emerging markets face higher acquisition costs. These tariffs are contributing to increased treatment and diagnostic expenses. However, they are also supporting localized equipment manufacturing, regional supplier development, and domestic innovation in neurological diagnostic solutions.
The hydrocephalus market research report is one of a series of new reports that provides hydrocephalus market statistics, including hydrocephalus industry global market size, regional shares, competitors with a hydrocephalus market share, detailed hydrocephalus market segments, market trends and opportunities, and any further data you may need to thrive in the hydrocephalus industry. This hydrocephalus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hydrocephalus is a medical condition where cerebrospinal fluid accumulates in brain cavities, leading to various cognitive abnormalities, deviating from its normal passage through the brain and spinal column spaces.
The primary types of hydrocephalus include congenital hydrocephalus, acquired hydrocephalus, normal-pressure hydrocephalus, and ex-vacuo hydrocephalus. Congenital hydrocephalus results from birth abnormalities or brain malformations, leading to excessive cerebrospinal fluid (CSF) accumulation. Hydrocephalus can be pediatric or adult, detectable through MRI, CT scans, head ultrasound, and others, with end-users including hospitals, diagnostic centers, academic institutions, and research organizations.
The hydrocephalus market consists of sales of shunts, valves, and accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The hydrocephalus market size is expected to see strong growth in the next few years. It will grow to $4.79 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing investments in neurological research, rising demand for early diagnosis solutions, expansion of advanced imaging technologies, growing focus on minimally invasive treatments, increased funding for neurological healthcare. Major trends in the forecast period include increasing use of advanced neuroimaging techniques, rising adoption of early diagnostic screening, growing focus on pediatric hydrocephalus management, expansion of clinical research in neurological disorders, enhanced integration of data-driven diagnostics.
The swift growth of healthcare infrastructure is anticipated to drive the hydrocephalus market in the coming years. Healthcare infrastructure encompasses the system of buildings, organizations, and resources dedicated to promoting, restoring, and maintaining health. It consists of various components that collaborate to provide healthcare services to individuals and communities. A well-developed healthcare infrastructure is essential for delivering comprehensive and specialized treatment to patients with hydrocephalus. It facilitates prompt diagnosis, appropriate therapy, and ongoing care, all of which contribute to better outcomes for individuals affected by this condition. For example, in May 2023, the American Health Care Association, a US-based nonprofit organization, reported that the United States had 6,129 hospitals, reflecting a 0.591% increase from 6,093 hospitals in the previous year. Therefore, the rapid expansion of healthcare infrastructure is propelling the hydrocephalus market.
Leading companies in the hydrocephalus market are innovating advanced products, including endovascularly implantable cerebrospinal fluid (CSF) shunts, to enhance the management of hydrocephalus by offering minimally invasive solutions for regulating CSF flow and alleviating intracranial pressure. An endovascularly implantable CSF shunt is a type of shunt system positioned within blood vessels (endovascularly) to address hydrocephalus, a condition marked by excessive CSF accumulation in the brain. For example, in August 2024, CereVasc Inc., a clinical-stage medical device company based in the US, received approval from the Food and Drug Administration (FDA) for its eShunt System. This medical device is designed for treating Normal Pressure Hydrocephalus (NPH) and includes an endovascularly implantable CSF shunt that aims to eliminate the need for invasive surgery and general anesthesia. The implantation of the eShunt will be conducted under local anesthesia using a minimally invasive femoral venous approach in an angiography suite, which is a specialized medical facility.
In June 2023, CereVasc, Inc., a US-based clinical-stage medical device company focused on treatments for communicating hydrocephalus, announced a corporate partnership with LianMedical to expand hydrocephalus care in Asia. Through this collaboration, the companies aim to address unmet needs in hydrocephalus treatment by making minimally invasive solutions for communicating hydrocephalus available to a broader patient population. LianMedical is a China-based medical device company.
Major companies operating in the hydrocephalus market are Johnson & Johnson Corporation, Medtronic plc, MIZUHO Co. Ltd., B. Braun Melsungen AG, Helios Hospital, Texas Children's Hospital, Boston Children’s Hospital, Karl Storz SE and Co. KG, Integra LifeSciences Corporation, Children's National Hospital, Natus Medical Incorporated, Aesculap Inc., Sophysa SA, Anadolu Medical Center, Christoph Miethke GmbH & Co. KG, Moller Medical GmbH, Spiegelberg GmbH & Co. KG, Delta Surgical Limited, Kaneka Medix Corporation, Tokibo Co. Ltd.
North America was the largest region in the hydrocephalus market in 2025. The regions covered in the hydrocephalus market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hydrocephalus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the hydrocephalus market by increasing costs of imported imaging equipment, diagnostic devices, surgical tools, and electronic monitoring systems. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported medical technologies, while emerging markets face higher acquisition costs. These tariffs are contributing to increased treatment and diagnostic expenses. However, they are also supporting localized equipment manufacturing, regional supplier development, and domestic innovation in neurological diagnostic solutions.
The hydrocephalus market research report is one of a series of new reports that provides hydrocephalus market statistics, including hydrocephalus industry global market size, regional shares, competitors with a hydrocephalus market share, detailed hydrocephalus market segments, market trends and opportunities, and any further data you may need to thrive in the hydrocephalus industry. This hydrocephalus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hydrocephalus is a medical condition where cerebrospinal fluid accumulates in brain cavities, leading to various cognitive abnormalities, deviating from its normal passage through the brain and spinal column spaces.
The primary types of hydrocephalus include congenital hydrocephalus, acquired hydrocephalus, normal-pressure hydrocephalus, and ex-vacuo hydrocephalus. Congenital hydrocephalus results from birth abnormalities or brain malformations, leading to excessive cerebrospinal fluid (CSF) accumulation. Hydrocephalus can be pediatric or adult, detectable through MRI, CT scans, head ultrasound, and others, with end-users including hospitals, diagnostic centers, academic institutions, and research organizations.
The hydrocephalus market consists of sales of shunts, valves, and accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Hydrocephalus Market Characteristics
3. Hydrocephalus Market Supply Chain Analysis
4. Global Hydrocephalus Market Trends and Strategies
5. Hydrocephalus Market Analysis of End Use Industries
7. Global Hydrocephalus Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Hydrocephalus Total Addressable Market (TAM) Analysis for the Market
9. Hydrocephalus Market Segmentation
10. Hydrocephalus Market Regional and Country Analysis
11. Asia-Pacific Hydrocephalus Market
12. China Hydrocephalus Market
13. India Hydrocephalus Market
14. Japan Hydrocephalus Market
15. Australia Hydrocephalus Market
16. Indonesia Hydrocephalus Market
17. South Korea Hydrocephalus Market
18. Taiwan Hydrocephalus Market
19. South East Asia Hydrocephalus Market
20. Western Europe Hydrocephalus Market
21. UK Hydrocephalus Market
22. Germany Hydrocephalus Market
23. France Hydrocephalus Market
24. Italy Hydrocephalus Market
25. Spain Hydrocephalus Market
26. Eastern Europe Hydrocephalus Market
27. Russia Hydrocephalus Market
28. North America Hydrocephalus Market
29. USA Hydrocephalus Market
30. Canada Hydrocephalus Market
31. South America Hydrocephalus Market
32. Brazil Hydrocephalus Market
33. Middle East Hydrocephalus Market
34. Africa Hydrocephalus Market
36. Hydrocephalus Market Competitive Landscape and Company Profiles
37. Hydrocephalus Market Other Major and Innovative Companies
40. Hydrocephalus Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Hydrocephalus Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses hydrocephalus market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for hydrocephalus? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hydrocephalus market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Congenital Hydrocephalus; Acquired Hydrocephalus; Normal-Pressure Hydrocephalus2) By Age Group: Pediatric; Adult
3) By Diagnostics: MRI; CT Scan; Head Ultrasound; Other Diagnostics
4) By End User: Hospitals; Diagnostic Centers; Academic Institutions; Research Organizations
Subsegments:
1) By Congenital Hydrocephalus: Associated With Genetic Disorders; Associated With Neural Tube Defects2) By Acquired Hydrocephalus: Post-Traumatic Hydrocephalus; Hydrocephalus Due To Tumors; Hydrocephalus Following Infection
3) By Normal-Pressure Hydrocephalus (NPH): Idiopathic Normal-Pressure Hydrocephalus; Secondary Normal-Pressure Hydrocephalus
Companies Mentioned: Johnson & Johnson Corporation; Medtronic plc; MIZUHO Co. Ltd.; B. Braun Melsungen AG; Helios Hospital; Texas Children's Hospital; Boston Children’s Hospital; Karl Storz SE and Co. KG; Integra LifeSciences Corporation; Children's National Hospital; Natus Medical Incorporated; Aesculap Inc.; Sophysa SA; Anadolu Medical Center; Christoph Miethke GmbH & Co. KG; Moller Medical GmbH; Spiegelberg GmbH & Co. KG; Delta Surgical Limited; Kaneka Medix Corporation; Tokibo Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Hydrocephalus market report include:- Johnson & Johnson Corporation
- Medtronic plc
- MIZUHO Co. Ltd.
- B. Braun Melsungen AG
- Helios Hospital
- Texas Children's Hospital
- Boston Children’s Hospital
- Karl Storz SE and Co. KG
- Integra LifeSciences Corporation
- Children's National Hospital
- Natus Medical Incorporated
- Aesculap Inc.
- Sophysa SA
- Anadolu Medical Center
- Christoph Miethke GmbH & Co. KG
- Moller Medical GmbH
- Spiegelberg GmbH & Co. KG
- Delta Surgical Limited
- Kaneka Medix Corporation
- Tokibo Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.87 Billion |
| Forecasted Market Value ( USD | $ 4.79 Billion |
| Compound Annual Growth Rate | 5.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
